Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-001631
Filing Date
2024-02-14
Accepted
2024-02-14 10:02:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. p24-0804sc13ga.htm SC 13G/A 70066
  Complete submission text file 0000902664-24-001631.txt   71760
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88806 | Film No.: 24633429
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)